{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:05:42Z","timestamp":1789185942887,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejso.2026.111494","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:17:21Z","timestamp":1771658241000},"page":"111494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis between peristaltic and syringe nebulization systems: Advancing high-pressure drug delivery for pressurized intraperitoneal aerosol chemotherapy (PIPAC)"],"prefix":"10.1016","volume":"52","author":[{"given":"Qiming","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingcong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1799-4841","authenticated-orcid":false,"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111494_bib1","first-page":"49","article-title":"The contemporary management of peritoneal metastasis: a journey from the cold past of treatment futility to a warm present and a bright future","volume":"73","author":"Foster","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2026.111494_bib2","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00313.2004","article-title":"The transport barrier in intraperitoneal therapy","volume":"288","author":"Flessner","year":"2005","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ejso.2026.111494_bib3","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","article-title":"High interstitial fluid pressure - an obstacle in cancer therapy","volume":"4","author":"Heldin","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejso.2026.111494_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40265-022-01828-7","article-title":"Intraperitoneal chemotherapy for unresectable peritoneal surface malignancies","volume":"83","author":"Guchelaar","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.ejso.2026.111494_bib5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jamaoncol.2021.0580","article-title":"Hyperthermic intraperitoneal chemotherapy for ovarian and colorectal cancer: a review","volume":"7","author":"Van Stein","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2026.111494_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.21037\/tgh.2016.07.03","article-title":"Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in advanced gastric cancer","volume":"1","author":"Wu","year":"2016","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2026.111494_bib7","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3390\/cancers16101929","article-title":"Efficacy of cytoreductive surgery (CRS) + HIPEC in gastric cancer with peritoneal metastasis: systematic review and meta-analysis","volume":"16","author":"Langellotti","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2026.111494_bib8","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","article-title":"Description of a novel approach for intraperitoneal drug delivery and the related device","volume":"26","author":"Solass","year":"2012","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ejso.2026.111494_bib9","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111494_bib10","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/cancers15041125","article-title":"10 years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis","volume":"15","author":"Di Giorgio","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"13","key":"10.1016\/j.ejso.2026.111494_bib11","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1245\/s10434-023-14353-y","article-title":"Results of the first phase I PIPAC trial in the United States: braving the storm","volume":"30","author":"Sun","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111494_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/pp-2021-0154","article-title":"A systematic review on quality of life (QoL) of patients with peritoneal metastasis (PM) who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"7","author":"Li","year":"2022","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ejso.2026.111494_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107250","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in patients with ovarian cancer: a systematic review","volume":"49","author":"Taliento","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111494_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103846","article-title":"Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for gastric cancer with peritoneal metastases: a systematic review by the PIPAC UK collaborative","volume":"180","author":"Case","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejso.2026.111494_bib15","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.21037\/jgo-20-257","article-title":"Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal Metastases\u2014A systematic review","volume":"12","author":"Lurvink","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ejso.2026.111494_bib16","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.3390\/cancers16213661","article-title":"Pressurized intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a systematic review of the evidence","volume":"16","author":"Sleiman","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2026.111494_bib17","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00404-024-07586-z","article-title":"Efficacy and safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in ovarian cancer: a systematic review of current evidence","volume":"310","author":"Pavone","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejso.2026.111494_bib18","doi-asserted-by":"crossref","first-page":"znae116","DOI":"10.1093\/bjs\/znae116","article-title":"Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysis","volume":"111","author":"Guchelaar","year":"2024","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2026.111494_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/pp-2016-0011","article-title":"Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the peritoneal regression grading score (PRGS)","volume":"1","author":"Solass","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ejso.2026.111494_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1515\/pp-2022-0108","article-title":"Importance of biopsy site selection for peritoneal regression grading score (PRGS) in peritoneal metastasis treated with repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"7","author":"Fallah","year":"2022","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ejso.2026.111494_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/pp-2022-0118","article-title":"Peritoneal regression grading score (PRGS) in peritoneal metastasis: how many biopsies should be examined?","volume":"7","author":"Solass","year":"2022","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ejso.2026.111494_bib22","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"P","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejso.2026.111494_bib23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy","volume":"21","author":"Solass","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111494_bib24","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1245\/s10434-012-2840-2","article-title":"Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"20","author":"Blanco","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111494_bib25","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.21873\/anticanres.13062","article-title":"No renal toxicity after repeated treatment with pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with unresectable peritoneal metastasis","volume":"38","author":"Larbre","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2026.111494_bib26","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00464-016-5174-5","article-title":"Technical description of the microinjection pump (MIP\u00ae) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"31","author":"G\u00f6hler","year":"2017","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ejso.2026.111494_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/cancers12030633","article-title":"Evaluation of a novel prototype for pressurized intraperitoneal aerosol chemotherapy","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2026.111494_bib28","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1590\/s0102-865020170120000007","article-title":"A prototype single-port device for pressurized intraperitoneal aerosol chemotherapy. Technical feasibility and local drug distribution","volume":"32","author":"Seitenfus","year":"2017","journal-title":"Acta Cir Bras"},{"key":"10.1016\/j.ejso.2026.111494_bib29","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s10877-021-00790-1","article-title":"Lag times to steady state drug delivery by continuous intravenous infusion: direct comparison of peristaltic and syringe pump performance identifies contributions from infusion system dead volume and pump startup characteristics","volume":"36","author":"Gibson","year":"2022","journal-title":"J Clin Monit Comput"},{"key":"10.1016\/j.ejso.2026.111494_bib30","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1213\/ANE.0000000000002396","article-title":"Understanding infusion pumps","volume":"126","author":"Mandel","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ejso.2026.111494_bib31","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1213\/ANE.0000000000001707","article-title":"Drug infusion systems: technologies, performance, and pitfalls","volume":"124","author":"Kim","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ejso.2026.111494_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.sna.2021.112602","article-title":"A review of peristaltic micropumps","volume":"326","author":"Forouzandeh","year":"2021","journal-title":"Sens Actuators Phys"},{"key":"10.1016\/j.ejso.2026.111494_bib33","first-page":"5522","article-title":"Miniaturized peristaltic rotary pump for non-continuous drug dosing","volume":"2019","author":"Tamadon","year":"2019","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc IEEE Eng Med Biol Soc Annu Int Conf"},{"key":"10.1016\/j.ejso.2026.111494_bib34","doi-asserted-by":"crossref","DOI":"10.1063\/1.4973513","article-title":"Packaged peristaltic micropump for controlled drug delivery application","volume":"88","author":"Vinayakumar","year":"2017","journal-title":"Rev Sci Instrum"},{"key":"10.1016\/j.ejso.2026.111494_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/srep26251","article-title":"In vivo organ specific drug delivery with implantable peristaltic pumps","volume":"6","author":"Speed","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2026.111494_bib36","doi-asserted-by":"crossref","DOI":"10.21037\/jgo-2024-1009","article-title":"A novel nebulized drug delivery system based on an innovative high-pressure peristaltic pump availably applied to pressurized intraperitoneal aerosol chemotherapy","volume":"16","author":"Li","year":"2025","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ejso.2026.111494_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/pp-2022-0102","article-title":"Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"7","author":"Sgarbura","year":"2022","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ejso.2026.111494_bib38","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1245\/s10434-015-4954-9","article-title":"Exploring the spatial drug distribution pattern of pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"23","author":"Khosrawipour","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111494_bib39","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.21873\/anticanres.11008","article-title":"Evaluating the effect of micropump\u00a9 position, internal pressure and doxorubicin dosage on efficacy of pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model","volume":"36","author":"Khosrawipour","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2026.111494_bib40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1460-9592.2001.00730.x","article-title":"Start-up delays of infusion syringe pumps","volume":"11","author":"Neff","year":"2001","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.ejso.2026.111494_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300241","article-title":"Performance of different nebulizers in clinical use for pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"19","author":"G\u00f6hler","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ejso.2026.111494_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1213\/01.ane.0000438349.21617.2f","article-title":"Time-delay when updating infusion rates in the graseby 3400 pump results in reduced drug delivery","volume":"118","author":"Sarraf","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ejso.2026.111494_bib43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jviscsurg.2022.10.001","article-title":"PIPAC nebulizer: how to test the new devices in the market, expert recommendations","volume":"160","author":"Pocard","year":"2023","journal-title":"J Vis Surg"},{"key":"10.1016\/j.ejso.2026.111494_bib44","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s00464-020-07546-z","article-title":"Comparison between microcatheter and nebulizer for generating pressurized IntraPeritoneal aerosol chemotherapy (PIPAC)","volume":"35","author":"Toussaint","year":"2021","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ejso.2026.111494_bib45","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.21873\/anticanres.15362","article-title":"Ideal nozzle position during pressurized intraperitoneal aerosol chemotherapy in an ex vivo model","volume":"41","author":"Piao","year":"2021","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2026.111494_bib46","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1038\/s41598-022-10369-8","article-title":"Optimization of intraperitoneal aerosolized drug delivery using computational fluid dynamics (CFD) modeling","volume":"12","author":"Rahimi-Gorji","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2026.111494_bib47","article-title":"Comparative evaluation of nozzle designs for enhanced oxaliplatin delivery in pressurized IntraPeritoneal aerosol chemotherapy: an in vivo study of a porcine model","author":"Karam","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111494_bib48","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-025-17602-4","article-title":"Design and validation of an impaction-nozzle nebuliser for enhanced distribution uniformity in pressurised intraperitoneal aerosol chemotherapy (PIPAC) applications","author":"Sautkin","year":"2025","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326001137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326001137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:05:33Z","timestamp":1789182333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326001137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0748798326001137"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111494","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis between peristaltic and syringe nebulization systems: Advancing high-pressure drug delivery for pressurized intraperitoneal aerosol chemotherapy (PIPAC)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111494"}}